|
1
|
Long K and Suresh K: Pulmonary toxicity of
systemic lung cancer therapy. Respirology. 25(Suppl 2): 72–79.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Minna JD, Roth JA and Gazdar AF: Focus on
lung cancer. Cancer Cell. 1:49–52. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang X, Mo C, Wang Y, Wei D and Xiao H:
Anti-tumour strategies aiming to target tumour-associated
macrophages. Immunology. 138:93–104. 2013. View Article : Google Scholar :
|
|
4
|
Roosen DA, Blauwendraat C, Cookson MR and
Lewis PA: DNAJC proteins and pathways to parkinsonism. Febs J.
286:3080–3094. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zylicz M, Yamamoto T, McKittrick N, Sell S
and Georgopoulos C: Purification and properties of the dnaJ
replication protein of Escherichia coli. J Biol Chem.
260:7591–7598. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choi J, Djebbar S, Fournier A and Labrie
C: The co-chaperone DNAJC12 binds to Hsc70 and is upregulated by
endoplasmic reticulum stress. Cell Stress Chaperones. 19:439–446.
2014. View Article : Google Scholar :
|
|
7
|
Anikster Y, Haack TB, Vilboux T,
Pode-Shakked B, Thöny B, Shen N, Guarani V, Meissner T, Mayatepek
E, Trefz FK, et al: Biallelic mutations in DNAJC12 cause
hyperphenylalaninemia, dystonia, and intellectual disability. Am J
Hum Genet. 100:257–266. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li M, Yang Q, Yi S, Qin Z, Luo J and Fan
X: Two novel mutations in DNAJC12 identified by whole-exome
sequencing in a patient with mild hyperphenylalaninemia. Mol Genet
Genomic Med. 8:e13032020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gallego D, Leal F, Gámez A, Castro M,
Navarrete R, Sanchez- Lijarcio O, Vitoria I, Bueno-Delgado M,
Belanger-Quintana A, Morais A, et al: Pathogenic variants of
DNAJC12 and evaluation of the encoded cochaperone as a genetic
modifier of hyperphenylalaninemia. Human Mutation. 41:1329–1338.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan Y, Yang Zh, Li F, Hu XC, Yue YW, Yang
J, Liu YT, Liu H, Wang YL, Shi CH and Xu YM: DNAJC12 mutation is
rare in Chinese Han population with Parkinson's disease. Neurobiol
Aging. 68:159.e1–159.e2. 2018. View Article : Google Scholar
|
|
11
|
He HL, Lee YE, Chen HP, Hsing CH, Chang
IW, Shiue YL, Lee SW, Hsu CT, Lin LC, Wu TF and Li CF:
Overexpression of DNAJC12 predicts poor response to neoadjuvant
concurrent chemoradiotherapy in patients with rectal cancer. Exp
Mol Pathol. 98:338–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Uno Y, Kanda M, Miwa T, Umeda S, Tanaka H,
Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, et al:
Increased expression of DNAJC12 is associated with aggressive
phenotype of gastric cancer. Ann Surg Oncol. 26:836–844. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
De Bessa SA, Salaorni S, Patrão DF, Neto
MM, Brentani MM and Nagai MA: JDP1 (DNAJC12/Hsp40) expression in
breast cancer and its association with estrogen receptor status.
Int J Mol Med. 17:363–367. 2006.PubMed/NCBI
|
|
14
|
Martin-Orozco E, Sanchez-Fernandez A,
Ortiz-Parra I and Ayala-San Nicolas M: WNT Signaling in tumors: The
way to evade drugs and immunity. Front Immunol. 10:28542019.
View Article : Google Scholar
|
|
15
|
Peifer M, McCrea PD, Green KJ, Wieschaus E
and Gumbiner BM: The vertebrate adhesive junction proteins
beta-catenin and plakoglobin and the Drosophila segment polarity
gene armadillo form a multigene family with similar properties. J
Cell Biol. 118:681–691. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haseeb M, Pirzada RH, Ain QU and Choi S:
Wnt signaling in the regulation of immune cell and cancer
therapeutics. Cells. 8:13802019. View Article : Google Scholar
|
|
17
|
Stewart DJ: Wnt signaling pathway in
non-small cell lung cancer. J Natl Cancer Inst. 106:djt3562014.
View Article : Google Scholar
|
|
18
|
Krishnamurthy N and Kurzrock R: Targeting
the Wnt/beta-catenin pathway in cancer: Update on effectors and
inhibitors. Cancer Treat Rev. 62:50–60. 2018. View Article : Google Scholar
|
|
19
|
Nakayama S, Sng N, Carretero J, Welner R,
Hayashi Y, Yamamoto M, Tan AJ, Yamaguchi N, Yasuda H, Li D, et al:
β-catenin contributes to lung tumor development induced by EGFR
mutations. Cancer Res. 74:5891–5902. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang X, Ma H, Han L, Zheng W, Lu YB, Chen
XF, Liang ST, Wei GH, Zhang ZQ, Chen HZ and Liu DP: SIRT1
deacetylates the cardiac transcription factor Nkx2.5 and inhibits
its transcriptional activity. Sci Rep. 6:365762016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expres- sion data using real-time quantitative PCR
and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Cui X, Song L, Bai Y, Wang Y, Wang B and
Wang W: Stromal interaction molecule 1 regulates growth, cell
cycle, and apoptosis of human tongue squamous carcinoma cells.
Biosci Rep. 37:BSR201605192017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu R, Zhao B, Ren X, Wu S, Liu M, Wang Z
and Liu W: MiR-27a-3p targeting GSK3β promotes triple-negative
breast cancer proliferation and migration through Wnt/β-catenin
pathway. Cancer Manag Res. 12:6241–6249. 2020. View Article : Google Scholar :
|
|
24
|
Kim JY, Kim HJ, Jung CW, Lee TS, Kim EH
and Park MJ: CXCR4 uses STAT3-mediated slug expression to maintain
radioresistance of non-small cell lung cancer cells: Emerges as a
potential prognostic biomarker for lung cancer. Cell Death Dis.
12:482021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sivaraman A, Kim D, Bhattarai D, Kim M,
Lee HY, Lim S, Kong J, Goo JI, Shim S, Lee S, et al: Synthesis and
structure-activity relationships of arylsulfonamides as AIMP2-DX2
inhibitors for the development of a novel anticancer therapy. J Med
Chem. 63:5139–5158. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang G, Meng W, Huang X, Zhu W, Yin C,
Wang C, Fassan M, Yu Y, Kudo M, Xiao S, et al: miR-196b-5p-mediated
downregulation of TSPAN12 and GATA6 promotes tumor progression in
non-small cell lung cancer. Proc Natl Acad Sci USA. 117:4347–4357.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paolillo M and Schinelli S: Extracellular
matrix alterations in metastatic processes. Int J Mol Sci.
20:49472019. View Article : Google Scholar :
|
|
29
|
Wong KK, Jacks T and Dranoff G: NF-kappaB
fans the flames of lung carcinogenesis. Cancer Prev Res (Phila).
3:403–405. 2010. View Article : Google Scholar
|
|
30
|
Popper HH: Progression and metastasis of
lung cancer. Cancer Metastasis Rev. 35:75–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xia Z, Wu S, Wei X, Liao Y, Yi P, Liu Y
and Liu J and Liu J: Hypoxic ER stress suppresses β-catenin
expression and promotes cooperation between the transcription
factors XBP1 and HIF1α for cell survival. J Biol Chem.
294:13811–13821. 2019. View Article : Google Scholar : PubMed/NCBI
|
